Skin cancer and non-Hodgkin's lymphoma: Examining the link

Dermatologic Surgery

Volumn 31, Issue 1, 2005, Pages 76-82

  Hu, Shasa ^a   Federman, Daniel G ^b,c   Ma, Fangchao ^a,d   Kirsner, Robert S ^a,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CLINICAL PRACTICE; CORRELATION ANALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MEDLINE; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN EXAMINATION; SOCIAL STATUS; SOLAR RADIATION; ULTRAVIOLET RADIATION;

EID: 11844292715     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200501000-00014     Document Type: Review

References (67)

1. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001;45:579-86.
2. NIH Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
3. Ferrini R, Perlman M, Hill L. American College of Preventive Medicine policy statement: screening for skin cancer. Am J Prev Med 1998;14:80-2.
4. Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol 1993;28:628-31.
5. Guidelines of care for basal cell carcinoma. J Am Acad Dermatol 1992;26:117-20.
6. Kaminester LH. Crucial importance of the complete skin examination. J Am Acad Dermatol 1985;13:150-3.
7. Leffell DJ, Berwick M, Bolognia J. The effect of pre-education on patient compliance with full-body examination in a public skin cancer screening. J Dermatol Surg Oncol 1993;19:660-3.
8. Federman DG, Concato J, Kirsner RS. Comparison of dermatologic diagnoses by primary care practitioners and dermatologists. A review of the literature. Arch Fam Med 1999;8:170-2.
9. Helfand M, Mahon SM, Eden KB, et al. Screening for skin cancer. Am J Prev Med 2001;20(3 Suppl):47-58.
10. Karagas MR, Stukel TA, Greenberg ER, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 1992;267:3305-10.
11. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997;277:1439-44.
12. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984;72:257-66.
13. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995;75(2 Suppl):607-12.
14. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63(1-3):8-18.
15. Gloster HM Jr,, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
16. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000;25:459-63.
17. Geller AC, Annas GD. Epidemiology of melanoma and non-melanoma skin cancer. Semin Oncol Nurs 2003;19(1):2-11.
18. Schenk M, Severson RK, Pawlish KS. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma. Cancer 1998;82:1672-76.
19. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
20. Ries L, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1975-2000. Bethesda (MD): National Cancer Institute, 2003.
21. Miller B, Kolonel LN, Bernstein L, et al., editors. Racial/ethnic patterns of cancer in the United States 1988-1992. Bethesda (MD): National Cancer Institute, 1996.
22. Ries L, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1973-1999. Bethesda (MD): National Cancer Institute, 2002.
23. Kirsner RS, Federman DG. The epidemiology of non-Hodgkin's lymphoma. Conn Med 1996;60:579-82.
24. Cartwright R, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 1994;14:387-94.
25. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992;52(19 Suppl): 5432s-40s.
26. Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 1992;120:45-173.
27. Beddingfield FC III. The melanoma epidemic: res ipsa loquitur. Oncologist 2003;8:459-65.
28. Wei Q, Lee JE, Gershenwald JE, et al. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 2003;95:308-15.
29. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94:2015-23.
30. National Cancer Institute Cancer statistics review 1973-1987. Bethesda (MD): National Institutes of Health, 1990.
31. Bray I, Brennan P, Boffetta P. Recent trends and future projections of lymphoid neoplasms - a bayesian age-period-cohort analysis. Cancer Causes Control 2001;12:813-20.
32. Davis DL, Hoel D, Fox J, Lopez A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 1990;336:474-81.
33. Tajima K. Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL). Cancer Metastasis Rev 1988;7:223-41.
34. Doll R. Nature and nurture: possibilities for cancer control. Carcinogenesis 1996;17:177-84.
35. Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol 2000;12:383-94.
36. Mueller N. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Syndr 1999;21 Suppl 1:S5-10.
37. Mueller N. Another view of the epidemiology of non-Hodgkin's lymphoma. Oncology (Huntingt) 1994;8(9):83.
38. Zheng T, Mayne ST, Boyle P, et al. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer 1992;70:840-9.
39. Green MH, Petit-Frere C, Clingen PH, et al. Possible effects of sunlight on human lymphocytes. J Epidemiol 1999;9(6 Suppl):S48-57.
40. Kripke ML. Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 1994;54:6102-5.
41. Goettsch W, Garssen J, de Gruijl FR, van Loveren H. UV-B and the immune system. A review with special emphasis on T cell-mediated immunity. Thymus 1993;21:93-114.
42. Whiteman DC, Green AC. Melanoma and sun exposure: where are we now? Int J Dermatol 1999;38:481-9.
43. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996;73:945-50.
44. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared etiology? Int J Cancer 1995;62:519-22.
45. Adami J, Frisch M, Yuen J, et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995;310:1491-5.
46. Surveillance Epidemiology, and End Results (SEER) Program. SEER*Stat database: incidence - SEER 9 regs public-use (1997-2000). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2003, based on Nov 2002 submission. Available at: www.seer.cancer.gov (accessed October 7, 2004).
47. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001;91:874-80.
48. McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer 2003;88:74-8.
49. Riou JP, Ariyan S, Brandow KR, Fielding LP. The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 1995;130:1056-61.
50. McKenna DB, Doherty VR, McLaren KM, Hunter JA. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? Br J Dermatol 2000;143:171-3.
51. Tsao H, Kwitkiwski K, Sober AJ. A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma. J Am Acad Dermatol 2002;46:55-61.
52. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995;141:916-22.
53. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996;74:1847-50.
54. Hemminki K, Dong C. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 2000;136:647-51.
55. Troyanova P, Danon S, Ivanova T. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 2002;49:81-5.
56. Friedman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000;11:891-7.
57. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85:1932-7.
58. Brennan P, Coates M, Armstrong B, et al. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 2000;82:1344-7.
59. Adami J, Gridley G, Nyren O, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999;80:641-5.
60. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997;73:198-203.
61. Vagero D, Swerdlow AJ, Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 1990;47:317-24.
62. Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996;312:1128-31.
63. Hartge P, Devesa SS, Grauman D, et al. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 1996;88:298-300.
64. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997;314:1451-5.
65. Hu S, Ma F, Collado-Mesa F, Kirsner RS. Ultraviolet radiation and incidence of non-Hodgkin's lymphoma among Hispanics in the US.. Cancer Epidemiol Biomarkers Prev 2004;13:59-64.
66. Hakansson N, Floderus B, Gustavsson P, et al. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001;12:552-7.
67. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240-51.